Company Misappropriated Cocaine-Based Anesthetic Trade Secrets, Drug Maker Says

(December 4, 2019, 2:10 PM EST) -- PHILADELPHIA — A specialty pharmaceutical company sued its former business partner on Nov. 29 in a Pennsylvania federal court, alleging that the defendant misappropriated the company’s trade secret information pertaining to its cocaine hydrochloride 4 percent solution product and allowed the company’s competitors to use the information in violation of the Defend Trade Secrets Act (DTSA) (Genus Lifesciences Inc. v. Mallinckrodt LLC, et al., No. 19-5403, E.D. Pa.)....

Attached Documents

Related Sections